Coyle, Kathryn <br/><br/>
Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.  [electronic resource] 

 -  PharmacoEconomics  May 2016 
 - 509-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2027 
<br/><br/><label>Standard No.: </label>10.1007/s40273-015-0366-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Cost-Benefit Analysis<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Markov Chains<br/>Quality-Adjusted Life Years<br/>Sildenafil Citrate--economics<br/>Tadalafil--economics